Research

Hormonal

Oral semaglutide consistently reduces LDL cholesterol and triglycerides, but its effect on HDL cholesterol is inconsistent and clinically insignificant.

Oral semaglutide helps lower 'bad' cholesterol (LDL) and triglycerides in most patients with Type 2 Diabetes. However, do not expect it to reliably raise 'good' cholesterol (HDL), as studies show mixed and clinically insignificant results for HDL changes.

GoodQualifiesMEDIUM confidence
Four studies reported a favorable reduction in LDL cholesterol (−7.6 to −18.0 mg/dL) and triglycerides (−11.00 to −40.13 mg/dL). HDL cholesterol shows the least consistent findings... rendering the change in HDL value to be potentially insignificant clinically.
Stanislaus Ivanovich Krishnanda et al. · Journal of Clinical Medicine · 2025

Why this rating

Consistent trend in LDL/TG reduction across 4/5 studies, but HDL data is mixed and often non-significant.

Source

The Effect of Oral Semaglutide on Cardiovascular Risk Factors in Patients with Type 2 Diabetes: A Systematic Review

Stanislaus Ivanovich Krishnanda et al. · Journal of Clinical Medicine · 2025

DOI 10.3390/jcm14072239

systematic_review · n=5132Cited 5×
Read the paper
DOI resolved against Crossref · corpus check 2026-06-10

This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →